Publication | Open Access

Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer

Tumor BiologyGene AmplificationAdjuvant Anthracycline-based ChemotherapyBreast OncologyMedicineImmunologyCancer Cell BiologyPathologyBreast CancerCancer TreatmentOncologyRadiation OncologyCancer ResearchTopoisomerase Iiα Expression